Profiling of the fecal microbiota and circulating microRNA-16 in IBS subjects with Blastocystis infection : a case-control study.
Blastocystis
Fecal microbiota
IBS
MicroRNA
mir-16
Journal
European journal of medical research
ISSN: 2047-783X
Titre abrégé: Eur J Med Res
Pays: England
ID NLM: 9517857
Informations de publication
Date de publication:
06 Nov 2023
06 Nov 2023
Historique:
received:
11
06
2023
accepted:
09
10
2023
medline:
8
11
2023
pubmed:
7
11
2023
entrez:
7
11
2023
Statut:
epublish
Résumé
Irritable bowel syndrome (IBS) is a prevalent gastrointestinal (GI) tract disorder. Although the main reason for IBS is not clear, the interaction between intestinal microorganisms and the gut barrier seems to play an important role in pathogenesis of IBS. The current study aimed to investigate the effect of Blastocystis on the gut microbiota profile and the circulation levels of microRNA (mir)-16 of IBS patients compared to healthy subjects. Stool and blood samples were collected from 80 participants including 40 samples from each IBS and healthy group. Upon DNA extraction from stool samples, barcoding region and quantitative real-time PCR were analyzed to investigate Blastocystis and the microbiota profile, respectively. RNA was extracted from serum samples of included subjects and the expression of mir-16 was evaluated using stem-loop protocol and qreal-time PCR. Significant changes between IBS patients and healthy controls was observed in Firmicutes, Actinobacteria, Faecalibacterium, and Alistipes. In IBS patients, the relative abundance of Bifidobacteria was directly correlated with the presence of Blastocystis, while Alistipes was decreased with Blastocystis. Lactobacillus was significantly increased in Blastocystis carriers. In healthy subjects, the relative abundance of Bifidobacteria was decreased, but Alistipes was increased in Blastocystis carriers. The changes in the Firmicutes/Bacteroidetes ratio was not significant in different groups. The relative expression of mir-16 in Blastocystis-negative IBS patients and healthy carriers was significantly overexpressed compared to control group. The presence of Blastocystis, decreased the relative expression of mir-16 in IBS patients compared to Blastocystis-negative IBS patients. The present study revealed that Blastocystis has the ability to change the abundance of some phyla/genera of bacteria in IBS and healthy subjects. Moreover, Blastocystis seems to modulate the relative expression of microRNAs to control the gut atmosphere, apply its pathogenicity, and provide a favor niche for its colonization.
Identifiants
pubmed: 37932792
doi: 10.1186/s40001-023-01441-8
pii: 10.1186/s40001-023-01441-8
pmc: PMC10626746
doi:
Substances chimiques
Circulating MicroRNA
0
MicroRNAs
0
MIRN16 microRNA, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
483Informations de copyright
© 2023. The Author(s).
Références
Gastroenterology. 2011 Nov;141(5):1792-801
pubmed: 21820992
Microbiome. 2016 Aug 31;4(1):47
pubmed: 27580855
Eur Rev Med Pharmacol Sci. 2008 Aug;12 Suppl 1:111-7
pubmed: 18924450
J Microbiol Methods. 2011 Sep;86(3):351-6
pubmed: 21704084
Toxins (Basel). 2021 Oct 26;13(11):
pubmed: 34822542
J Pers Med. 2021 Jan 08;11(1):
pubmed: 33429936
mSystems. 2018 Jun 26;3(3):
pubmed: 29963639
Cells. 2020 Aug 17;9(8):
pubmed: 32824536
J Neurogastroenterol Motil. 2022 Oct 30;28(4):540-548
pubmed: 36250361
Dig Dis. 2018;36(1):56-65
pubmed: 28683448
Gastroenterol Hepatol (N Y). 2013 Sep;9(9):560-9
pubmed: 24729765
Semin Cell Dev Biol. 2024 Feb 15;154(Pt C):364-373
pubmed: 36670037
J Clin Invest. 2020 Jan 2;130(1):438-450
pubmed: 31815740
Cell Mol Life Sci. 2022 Apr 18;79(5):245
pubmed: 35435504
ISME J. 2017 Dec;11(12):2848-2863
pubmed: 28837129
Am J Physiol Gastrointest Liver Physiol. 2011 Nov;301(5):G799-807
pubmed: 21737778
Front Med (Lausanne). 2022 Aug 11;9:940332
pubmed: 36035429
Front Microbiol. 2018 Jul 25;9:1600
pubmed: 30090090
Microbiome. 2019 Jun 13;7(1):91
pubmed: 31196177
Med Hypotheses. 2018 Jul;116:4-9
pubmed: 29857906
Gut Liver. 2021 Mar 15;15(2):253-261
pubmed: 32457278
Nat Rev Gastroenterol Hepatol. 2019 Aug;16(8):461-478
pubmed: 31123355
Ann Parasitol. 2022;68(1):77-85
pubmed: 35491688
ISME J. 2022 Sep;16(9):2181-2197
pubmed: 35729225
Theranostics. 2023 Feb 5;13(3):1165-1179
pubmed: 36793854
Microorganisms. 2022 Jan 31;10(2):
pubmed: 35208781
BMC Genomics. 2013 Nov 14;14:788
pubmed: 24225361
Biochem J. 2017 May 16;474(11):1823-1836
pubmed: 28512250
J Biol Chem. 2022 Nov;298(11):102461
pubmed: 36067883
J Clin Med. 2019 Oct 30;8(11):
pubmed: 31671546
Medicine (Baltimore). 2019 Feb;98(7):e14513
pubmed: 30762787
BMJ Qual Improv Rep. 2015 Nov 12;4(1):
pubmed: 26734433
BMC Microbiol. 2021 Oct 19;21(1):285
pubmed: 34666703
Turk J Med Sci. 2020 Mar 28;50(SI-2):1632-1641
pubmed: 32222124
Front Microbiol. 2023 Feb 24;14:1147945
pubmed: 36910213
Microorganisms. 2021 Dec 24;10(1):
pubmed: 35056483
Microbiol Spectr. 2021 Oct 31;9(2):e0048421
pubmed: 34549998
EBioMedicine. 2020 Jan;51:102562
pubmed: 31877418
PLoS One. 2010 Nov 18;5(11):e15484
pubmed: 21124983
Nat Med. 2021 Feb;27(2):321-332
pubmed: 33432175
Cell Microbiol. 2012 Sep;14(9):1474-84
pubmed: 22587300
Microbiome. 2015 Dec 09;3:73
pubmed: 26653757
Parasitol Res. 2012 Jul;111(1):487-91
pubmed: 22287022
PLoS Pathog. 2021 Feb 25;17(2):e1009253
pubmed: 33630979
Environ Microbiol. 2018 Sep;20(9):3201-3213
pubmed: 29749705
Front Immunol. 2020 Jun 09;11:906
pubmed: 32582143
Gut. 2017 Sep;66(9):1537-1538
pubmed: 28082316
BMC Microbiol. 2022 Apr 22;22(1):111
pubmed: 35459091
Appl Environ Microbiol. 2012 Feb;78(4):1107-12
pubmed: 22179250
J Transl Med. 2023 Feb 11;21(1):117
pubmed: 36774467
Nutrients. 2020 Apr 15;12(4):
pubmed: 32326604
Intest Res. 2015 Jan;13(1):11-8
pubmed: 25691839
Benef Microbes. 2012 Dec 1;3(4):287-97
pubmed: 22968374
Front Med (Lausanne). 2022 Jun 20;9:890127
pubmed: 35795640
Gastroenterology. 2017 Jan;152(1):111-123.e8
pubmed: 27725146
BMC Gastroenterol. 2021 Mar 5;21(1):105
pubmed: 33663411
J Water Health. 2021 Oct;19(5):687-704
pubmed: 34665764
Int J Biol Sci. 2021 Jan 31;17(3):712-727
pubmed: 33767583
Mol Cell Endocrinol. 2022 Apr 15;546:111572
pubmed: 35066114
Parasit Vectors. 2015 Sep 15;8:453
pubmed: 26373392